These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23987821)

  • 21. Bendamustine in chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
    Ujjani C; Cheson BD
    Expert Rev Anticancer Ther; 2010 Sep; 10(9):1353-65. PubMed ID: 20836669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of bendamustine in rituximab-refractory indolent B-cell non-Hodgkin lymphoma: review of a pivotal trial.
    Ujjani C; Cheson B
    Future Oncol; 2011 Jan; 7(1):9-14. PubMed ID: 21174533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapy-related acute myeloid leukemia in a patient with chronic lymphocytic leukemia treated with rituximab-bendamustine.
    García-Muñoz R; García DK; Roldán-Galiacho V; Merchante-Andreu M; Campeny-Najara A; Rabasa P
    Ann Hematol; 2014 Apr; 93(4):699-702. PubMed ID: 23907409
    [No Abstract]   [Full Text] [Related]  

  • 24. Bendamustine monotherapy in advanced and refractory chronic lymphocytic leukemia.
    Kath R; Blumenstengel K; Fricke HJ; Höffken K
    J Cancer Res Clin Oncol; 2001 Jan; 127(1):48-54. PubMed ID: 11206271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bendamustine: new perspective for an old drug in lymphoproliferative disorders.
    Montillo M; Ricci F; Tedeschi A; Vismara E; Morra E
    Expert Rev Hematol; 2010 Apr; 3(2):131-48. PubMed ID: 21083456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bendamustine: inadequate or outdated data.
    Prescrire Int; 2012 Mar; 21(125):64. PubMed ID: 22428184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical experience of bendamustine in relapsed or refractory Hodgkin lymphoma: a retrospective analysis of the French compassionate use program in 28 patients.
    Ghesquières H; Stamatoullas A; Casasnovas O; Morschhauser F; Gyan E; Gabarre J; Malphettes M; Clément L; Ferlay C; Brice P
    Leuk Lymphoma; 2013 Nov; 54(11):2399-404. PubMed ID: 23410099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in the diagnosis and treatment of patients with low grade lymphoma in Germany: years 2006-2009.
    Schmidt C; Fingerle-Rowson G; Boehme A; Brendel K; Fischer R; Gonnermann M; Höhler T; Kegel T; Kellermann L; Nusch A; Pönisch W; Wendtner C; Dreyling M
    Leuk Lymphoma; 2015 Mar; 56(3):694-702. PubMed ID: 24937122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of primary and secondary prophylaxis of chemotherapy-induced and febrile neutropenia in bendamustine plus rituximab regimens in patients with lymphoma and chronic lymphocytic leukemia: real-world, single-center experience.
    Moore L; Bartels T; Persky DO; Abraham I; Kumar A; McBride A
    Support Care Cancer; 2021 Aug; 29(8):4867-4874. PubMed ID: 33547525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short communication: bendamustine-related hemolytic anemia in chronic lymphocytic leukemia.
    Goldschmidt N; Gural A; Ben-Yehuda D; Gatt ME
    Cancer Chemother Pharmacol; 2013 Sep; 72(3):709-13. PubMed ID: 23907444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bendamustine-based therapy as first-line treatment for non-Hodgkin lymphoma.
    Gil L; Kazmierczak M; Kroll-Balcerzak R; Komarnicki M
    Med Oncol; 2014 May; 31(5):944. PubMed ID: 24752517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bendamustine: a review of its use in the management of indolent non-Hodgkin lymphoma.
    Plosker GL; Carter NJ
    Drugs; 2008; 68(18):2645-60. PubMed ID: 19093705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bendamustine therapy in chronic lymphocytic leukemia.
    Masiello D; Tulpule A
    Expert Opin Pharmacother; 2009 Jul; 10(10):1687-98. PubMed ID: 19527193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bendamustine.
    Keating MJ; Bach C; Yasothan U; Kirkpatrick P
    Nat Rev Drug Discov; 2008 Jun; 7(6):473-4. PubMed ID: 18511926
    [No Abstract]   [Full Text] [Related]  

  • 35. Bendamustine in CLL: How quickly will today's consensus become tomorrow's memory?
    Cheson BD
    Leuk Res; 2014 Nov; 38(11):1267-8. PubMed ID: 25260826
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma.
    Martin P; Chen Z; Cheson BD; Robinson KS; Williams M; Rajguru SA; Friedberg JW; van der Jagt RH; LaCasce AS; Joyce R; Ganjoo KN; Bartlett NL; Lemieux B; VanderWalde A; Herst J; Szer J; Bar MH; Cabanillas F; Dodds AJ; Montgomery PG; Pressnail B; Ellis T; Smith MR; Leonard JP
    Br J Haematol; 2017 Jul; 178(2):250-256. PubMed ID: 28419413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I-II study of bendamustine in patients with acute leukemia and high risk myelodysplastic syndrome.
    Chacar C; Jabbour E; Ravandi F; Borthakur G; Kadia T; Estrov Z; Rios MB; Cortes J; Kantarjian H
    Clin Lymphoma Myeloma Leuk; 2012 Jun; 12(3):197-200. PubMed ID: 22578814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial.
    Knauf WU; Lissitchkov T; Aldaoud A; Liberati AM; Loscertales J; Herbrecht R; Juliusson G; Postner G; Gercheva L; Goranov S; Becker M; Fricke HJ; Huguet F; Del Giudice I; Klein P; Merkle K; Montillo M
    Br J Haematol; 2012 Oct; 159(1):67-77. PubMed ID: 22861163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing premedications in the prevention of bendamustine infusion-related reactions.
    Tombleson RL; Ho V; Sokol L; Pinilla J; Wetzstein GA
    Cancer Control; 2012 Jul; 19(3):245-7. PubMed ID: 22710900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug essentials. An alkylating agent for CLL and NHL.
    Wilkes GM
    Oncology (Williston Park); 2009 Apr; 23(4 Suppl Nurse Ed):55-6. PubMed ID: 19856600
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.